J Khazir, S Ahmed, RK Thakur… - Current Topics in …, 2024 - ingentaconnect.com
COVID-19, stemming from SARS-CoV-2, poses a formidable threat to global healthcare, with a staggering 77 million confirmed cases and 690,067 deaths recorded till December 24 …
B Guo, H Wang, Y Zhang, C Wang, J Qin - Veterinary Research …, 2024 - Springer
Abstract Varicellovirus bovinealpha 1 (BoAHV-1) is one of the crucial pathogens of bovine respiratory diseases, and its pathogenic mechanism involves oxidative stress, inflammation …
DM Ramirez, S Dhiman, A Mukherjee… - RSC Medicinal …, 2024 - pubs.rsc.org
The emergence of aminoglycoside resistance has prompted the development of amphiphilic aminoglycoside derivatives which target bacterial membranes. Tobramycin and nebramine …
M Du, H Li, H Guo, X Zhang, H Rong, X Hao - Heliyon, 2024 - cell.com
Background The coronavirus disease 2019 (COVID-19) has been a global pandemic since it broke out, and integrated Chinese and Western medicine (ICWM) has played an important …
J Ding, J Li, Z Zhang, Y Du, Y Liu, P Wang… - … Medicine and Therapies, 2023 - Springer
Abstract Background Respiratory Syncytial Virus (RSV) stands out as a primary contributor to lower respiratory tract infections and hospitalizations, particularly in infants. Lonicerae …
MA Rahim, SK Singha, SA Foez, S Sinha… - Euroasian journal of …, 2023 - ncbi.nlm.nih.gov
A bstract The development of new and novel drugs starts following a path of targeting possible candidate drug, elucidation their mechanism of action, animal studies, and finally …
D Oktavianti, B Elya, I Putra… - Tropical Journal of Natural …, 2023 - researchgate.net
The 3-Chymotrypsine-Like Protease (3CLpro) is an enzyme that has a major function in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) life cycle. It can be …
P Nagu, P Sharma, A Parashar, M Sharma… - Anti-SARS-CoV-2 … - taylorfrancis.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel coronavirus that emerged in December 2019 from Wuhan, China, and has since caused a global …